Losing out in Land-Based Greenhouse Gas Removal
Exchanges: The Interdisciplinary Research Journal · 20.05.2026 · 13 (2) · 48-72
DOI: 10.31273/eirj.v13i2.1892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exchanges: The Interdisciplinary Research Journal, online erschienen am 20.05.2026. Verfasst von Catherine Price und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Biochar is an emergent technology that is currently being investigated for its greenhouse gas removal potential at scale. This provides an ideal opportunity to investigate the potential injustices that may arise with biochar production and deployment so that these can be addressed. We draw from original data collected in 2022—consisting of 37 semi-structured interviews with mostly UK-based stakeholders who have an interest or potential interest in biochar—supplemented with a document analysis. The paper uses the ‘multioptic vision’ model of who, what, and how to explore the potential injustices of biochar production and deployment. A relatively small number of potential distributive injustices, with slightly more multispecies injustices, were identified. Procedural, recognition, and cosmopolitan injustices may be associated with biochar production and deployment, but these were not identified by our stakeholders or by the organisations in the document analysis.
Zitieren
APA
Price, C., & Morris, C. (2026). Losing out in Land-Based Greenhouse Gas Removal. Exchanges: The Interdisciplinary Research Journal, 13(2), 48-72. https://doi.org/10.31273/eirj.v13i2.1892
Vancouver
Price C, Morris C. Losing out in Land-Based Greenhouse Gas Removal. Exchanges: The Interdisciplinary Research Journal. 2026;13(2):48-72. doi:10.31273/eirj.v13i2.1892
BibTeX
@article{Price2026,
author = {Price, Catherine and Morris, Carol},
title = {Losing out in Land-Based Greenhouse Gas Removal},
journal = {Exchanges: The Interdisciplinary Research Journal},
year = {2026},
volume = {13},
number = {2},
pages = {48--72},
doi = {10.31273/eirj.v13i2.1892}
}
EUVIMED